F4 FundFund
TeamPortfolioRaiseChampionsEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investorsSimilar Firms
Warm Fund

Vertical Venture Partners

vvp.vc · Palo Alto, CA

“Back founders with deep, first-hand domain expertise in specific industry verticals — those who have 'lived' the problem they are solving. Vertical-first software delivers faster time-to-value and stronger retention versus horizontal tools requiring heavy customization.”

$500K – $4M
Check Size
Leads & Follows
Lead Tendency
~1 Month
Timeline
01Investment Thesis

Back founders with deep, first-hand domain expertise in specific industry verticals — those who have 'lived' the problem they are solving. Vertical-first software delivers faster time-to-value and stronger retention versus horizontal tools requiring heavy customization.

Exclusion Criteria

No B2C, no capital-intensive businesses with extended development timelines, caution around heavily regulated industries with long sales cycles

02Investment Team
DS
David Schwab
Founder and Managing Director
BC
Brad Corona
Managing Director
PC
Paul Conley
Venture Partner
03F4 Research Brief

Vertical Venture Partners Research

Investment Thesis

Vertical Venture Partners (VVP) is a Palo Alto-based early-stage venture capital firm founded in 2015 by David Schwab, a former partner at Sierra Ventures and co-founder of Scopus Technology (acquired by Siebel Systems). The firm's core thesis is built around backing founders who possess deep, first-hand domain expertise in specific industry verticals — what they call founders who have lived the problem they are solving, accumulating the "scar tissue" that comes from years of operating within a particular industry.

VVP was founded on the insight that enterprise software buyers — particularly CIOs — had grown frustrated with horizontal technologies that required significant customization to fit their workflows. Instead, VVP bets on vertical-first solutions: software purpose-built for a single industry, from roofing contractors and trucking companies to ophthalmology practices and dental offices. This specificity allows portfolio companies to achieve faster time-to-value and stronger retention in their target markets.

Sector Focus

VVP invests across a wide range of industry verticals including:

  • Healthcare & Life Sciences: Patient billing, behavioral health, dental, ophthalmology, diabetes management, precision medicine tools
  • Transportation & Logistics: Diesel fuel discount platforms, fleet management, freight audit, AR automation for trucking
  • Insurance: Commercial insurance digitization, insurance-specific CRM
  • Retail & eCommerce: Loyalty programs, prescriptive analytics for supply chains
  • Construction & Real Estate: Construction monitoring, property management automation, house-flipping platforms
  • Agriculture: AI farm management
  • Cybersecurity: Deception-based threat detection, AI-powered SOC automation
  • Biotech & Life Sciences Tools: Microfluidics, single-cell analysis, genome engineering, drug development platforms
  • EdTech: AI reading tutors, student portfolio/career platforms
  • Media: Podcast networks and ad marketplaces

VVP explicitly avoids B2C investments and capital-intensive businesses with extended development timelines. They exercise caution around heavily regulated industries that create long sales cycles.

Stage Focus

VVP invests primarily in early-stage rounds:

  • Seed and Seed+: First checks of $500K–$2.5M for companies with working products and pilot customers. Pre-revenue investments are considered if the product is functional.
  • Series A: $3M–$4M checks for companies demonstrating product-market fit and revenue traction.

They reserve follow-on capital for their best-performing portfolio companies and prefer to be among the earliest institutional investors.

Check Size

  • Seed/Seed+: $500K – $2.5M
  • Series A: $3M – $4M
  • Total range: $500K – $4M

Geographic Focus

VVP invests nationwide across the United States, with a deliberate emphasis on companies located outside the Bay Area — markets where "access to capital is more constrained." This differentiated geographic thesis gives VVP access to strong deal flow from overlooked markets. Their headquarters is in Palo Alto, CA (853 Alma Street).

Team

David Schwab, Founder and Managing Director: David founded VVP after seven years as a partner at Sierra Ventures, where he built the Sierra CIO Advisory Board — a network that gave him direct insight into enterprise buyer pain points. Before VC, he co-founded Scopus Technology, an early CRM software company that IPO'd within seven years and was later sold to Siebel Systems. David holds undergraduate and graduate degrees in Aerospace Engineering from UC San Diego and Stanford.

Brad Corona, Managing Director: Brad joined VVP in early 2016, bringing a Wall Street background to complement the engineering-heavy founding team. He is known for VVP's collaborative culture — describing the firm as operating "more like a band" with no deal attribution, collective ownership, and a non-hierarchical partnership structure.

Dr. Paul Conley, PhD, Venture Partner: A builder and serial entrepreneur, Paul entered VC in 2007 after one of his startups was backed by an investor who then invited him to join. He specializes in deep tech at the frontier of physics, chemistry, and biology, and focuses on backing technical founders with novel approaches to complex problems.

Decision Process

VVP operates as a collaborative partnership. All investment decisions are made collectively by the team — Brad Corona describes the firm as functioning "more like a band" where deal attribution doesn't exist and all successes and failures are shared. Initial meetings are founder-focused, followed by team evaluations. Diligence emphasizes market opportunity and customer feedback, with extensive conversations with existing and prospective customers to validate the opportunity and go-to-market strategy.

Recent Activity

VVP has been actively investing through 2024 and 2025:

  • Barti (August 2025): $12M Series A for AI-powered EHR tech for ophthalmology
  • Inbox Health (September 2025): $20M funding round (cumulative $55M raised)
  • Zuub (July 2024): $9M Series A for dental practice RCM automation
  • Backflip (April 2024): $15M Series A; house-flipping SaaS exceeding $10M net revenue run rate
  • Alida Biosciences (June 2024): Series A with product launch

Portfolio Highlights

VVP has backed 50+ companies across their fund history. Notable investments include:

  • SOCi (Realized): Multi-location enterprise social media management — major exit
  • Embroker: Digital commercial insurance platform for small/mid-sized businesses
  • Mudflap: Diesel fuel discount platform for owner-operators in trucking
  • Roofr: Sales platform with proposals and measurements for roofing contractors
  • Concert Health: Collaborative care behavioral health integrated with primary care
  • Acalvio: Advanced deception-based cybersecurity for threat detection
  • Inscripta: Scalable digital genome engineering platform
  • Amira Learning: AI intelligent reading assistant (named Fast Company Most Innovative 2025)
  • JASK (Realized): AI-powered cybersecurity threat analysis (acquired)
  • Profitect (Realized): Prescriptive analytics for retail (acquired)
  • Portfolium (Realized): Higher education career platform (acquired)

Post-Investment Involvement

VVP tailors involvement to each founder's preferences. Support includes recruiting assistance, strategy development, and leveraging their extensive Strategic Advisory Board — 12 senior industry executives with backgrounds at Khosla Ventures, McKinsey, BMC Software, Merck, and the US Army — to open enterprise doors for portfolio companies.

Founder Preferences

VVP backs founders who have direct, personal experience with the problem they're solving — ideally having worked for years within the vertical they're addressing. They value execution focus, customer obsession, and founders motivated by building great products rather than by fundraising milestones. Technical founders are well-represented in the portfolio, particularly in deep tech and life sciences.

04Selected Portfolio
Biotech & Life Sciences
Alida Biosciences·Basilard Biotech·Cellsonics·Delix Therapeutics·GALT·Inscripta·Intabio·IONPath·NanoCellect·ONI·Partillion·Sensorygen·Hermes Biosciences
EdTech
Amira Learning·Portfolium
Enterprise Software
Autolab·Domos·Implentio·Inveterate·OnSiteIQ·PowWow Mobile·Profitect·Replify·Roofr·AgScout·SOCi·Upwell·Whiz.ai
Fintech & Payments
Backflip
Food & Beverage
Welby Health
Healthcare & Digital Health
Concert Health·Mongoose·Passio·Tasso·Zipari·Zuub·Inbox Health·Surf Therapeutics·Barti
Insurance
Embroker
Logistics & Supply Chain
BeyondTrucks·JASK·Mudflap
Manufacturing & Industrial
Grolltex·MolyWorks
Media & Entertainment
HeadGum
Security & Cybersecurity
Acalvio
Semiconductors & Hardware
Menlo Micro
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

See full activity (9) →
Invested in Mongoose AI, a healthcare SaaS platform providing enterprise-grade controls and AI support.
INVESTMENT·vvp.vc
MAY 2026
Led Surf Therapeutics' extended seed round ($6M total) for ultrasound neuromodulation biotech targeting immune diseases.
INVESTMENT·businesswire.com
MAR 2026
Invested in Hermes Biosciences in seed round.
INVESTMENT·vvp.vc
NOV 2025
Led $10M equity investment in Backflip.
INVESTMENT·vvp.vc
NOV 2025
Participated in Inbox Health's $20M growth round for AI-powered patient billing and communication platform.
INVESTMENT·healthcareittoday.com
OCT 15, 2025
06Frequent co-investors
PC
Paladin Capital Group
Both backed 7 of the same companies
Inscripta, Basilard Biotech, Cellsonics, Menlo Micro,
+3 moreNanoCellect, Acalvio, Hermes Biosciences
HV
Healthy Ventures
Both backed 3 of the same companies
Concert Health, Whiz.ai, Inbox Health
BC
Bullpen Capital
Both backed 2 of the same companies
Roofr, OnSiteIQ
JV
J2 Ventures
Both backed 2 of the same companies
Acalvio, Tasso
Find the investors for your round→
07Similar Firms
R
Redalpine
$500K – $5M · Pre-Seed · Seed
→
RC
Refactor Capital
$1M – $2M · Pre-Seed · Seed
→
N
Nomads
$500K – $50M · Pre-Seed · Seed
→
AE
Alpha Edison
$250K – $10M · Pre-Seed · Seed
→
LV
LifeX Ventures
Pre-Seed · Seed
→
Quick Reference
Check Size
$500K – $4M
Stages
Seed · Series A
Decision
Partnership · ~1 Month
Warm Intro
Not Required
Involvement
Board Seat
Location
Palo Alto, CA
Sector Focus
Real Estate & PropTechInsuranceBiotech & Life SciencesLogistics & Supply ChainEdTechEnterprise SoftwareSecurity & CybersecurityHealthcare & Digital Health
Models
Vertical SaaSDeep TechB2B Software
Technology
AI/ML
See all Real Estate & PropTech investors →See all Insurance investors →See all Biotech & Life Sciences investors →
Visit vvp.vc ↗

See how Vertical Venture Partners matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Real Estate & PropTechInsuranceBiotech & Life SciencesLogistics & Supply ChainEdTechEnterprise SoftwareSecurity & CybersecurityHealthcare & Digital Health

See how Vertical Venture Partners matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched July 25, 2026F4 Research Engine